Dianthus Therapeutics DNTH Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's current ratio?
- Dianthus Therapeutics (DNTH) reported current ratio of 29.3× in Q1 2026.
- How has Dianthus Therapeutics's current ratio changed year-over-year?
- Dianthus Therapeutics's current ratio increased by 83.0% year-over-year, from 16× to 29.3×.
- What is the long-term trend for Dianthus Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Dianthus Therapeutics's current ratio has grown at a 0.1% compound annual growth rate (CAGR), from 13.3× to 13.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.